Figure 4.
Repetitive Behavior Scale-Revised (RBS-R) sub-scores prior to the initiation of omalizumab (blue) and after the 6 month treatment period (red).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.